Nextleaf Awarded Jamaican Patent for its Foundational Extraction Process

Published: June 10, 2022

Nextleaf Awarded Jamaican Patent for its Foundational Extraction Process

Nextleaf Solutions Ltd., a federally regulated manufacturer and distributor of cannabis vapes and oils, announced today the Jamaica Intellectual Property Office has granted Nextleaf a patent for the Company’s foundational process for producing high-purity CBD and THC ingredients.

Nextleaf’s patented technology allows for oil-grade cannabis and hemp flower to be efficiently processed into a high-purity distilled cannabinoids. The resulting THC or CBD distillate is tasteless, odourless, standardized for potency, and ready to use as the hero ingredient in a wide range of products, including vapes, oils, softgels, transdermal or sublingual delivery, and water-soluble extracts.

The Company has been issued 18 U.S. patents, and over 95 patents globally, on cannabinoid processing including extraction, distillation, and acetylation. Nextleaf initially files its patents in the United States to create a priority date and allow for future filings in other selected jurisdictions. This is common in the field of intellectual property (“IP) protection. The Company owns issued patents in the United States, Canada, Mexico, Israel, Germany, Australia, Colombia, South Africa, the U.K., and across Europe. Nextleaf follows a global IP strategy of protecting the means to producing standardized cannabinoid-based products at scale within a regulated market.

Medical cannabis is currently legal in Jamaica and possession of small amounts of marijuana was decriminalized in 2015, with residents permitted to grow up to five plants for personal use only.

“This patent reinforces our vision of developing intellectual property that improves cannabis oil economics globally,” said Paul Pedersen, CEO of Nextleaf Solutions. “We believe there will be a regulated commercial market for cannabinoid-based products in Jamaica during the 20-year life of this patent.”

Nextleaf Issues Warrants
The Company has issued 500,000 warrants to purchase common shares of the Company to the holder of the convertible note issued on March 31, 2021 (the “Note”). The warrants were issued as consideration for revision of terms of the Note and are exercisable at a price of $0.138 per share for a period of 36 months from the date of issuance.

About Nextleaf Solutions Ltd.
Nextleaf® is a federally regulated manufacturer and distributor of cannabis vapes and oils under its award-winning prohibition-era brand, Glacial Gold™. The Company’s multi-patented ingredient processing technology transforms cannabis and hemp biomass into high-purity distillate at an industrial scale. Nextleaf is a low-cost producer of cannabis oils, and supplier of THC and CBD ingredients to qualified wholesale partners across Canada. Nextleaf is the first publicly traded company to be issued a U.S. patent for the industrial extraction and purification of cannabinoids. The Company has been issued 18 U.S. patents, and over 95 patents globally, on cannabinoid processing including distillation and acetylation. Nextleaf develops cannabinoid-based formulations and delivery technology through its Health Canada Research Licence with sensory evaluation of cannabis via human testing. For more information visit www.nextleafsolutions.com and www.Glacial.Gold

Follow the Company: TwitterLinkedInFacebook, and Instagram.
Follow Glacial Gold™InstagramTwitter, and Facebook.